News	Drug Formulary	Safety Net	Resources
	Drug Formulary Categories and Charges Search HA Drug Formulary Self-financed Drugs Available for Purchase by Patients at HA Pharmacy How we evaluate new drugs Governance Drug Management Committee Drug Advisory Committee Drug Formulary Committee Drug Selection Committee Drug & Therapeutics Committee Expert Panel Medication Safety Committee	Samaritan Fund Community Care Fund	Drug Education HA Drug Formulary Management Manual Frequently Asked Questions Useful Links

Expert Panel

Expert Panels are formed to provide professional support for DAC and DFC in the management of HA Drug Formulary. The number of Expert Panels may change as necessary.

Terms of Reference

In Support of DAC :
1. To provide expert opinions on introduction of new drugs, clinical guidelines or protocols upon request; and
2. To nominate representatives as DAC advisers upon invitation.
In Support of DFC :
1. To conduct biennial comprehensive review of the HA Drug Formulary and consultation on drug issues upon request;
2. To make recommendation on the proposed changes in the HA Drug Formulary;
3. To advise on the use of alternatives for obsolete drugs; and
4. To advise on appropriate use of unregistered and non-formulary drugs.

Composition

Co-convenors
1. DFC Chairperson and Chief Pharmacist
Members
1. One representative of relevant COCs or CCs on disease groups;
2. Cluster specialist representatives nominated by CCEs from all clusters; and
3. Two Cluster Clinical Stream Coordinators (Pharmacy) / Senior Pharmacists nominated by Chief Pharmacist.

Members’ tenure goes with the cycle of biennial comprehensive review of the HA Drug Formulary and all members can be re-appointed upon nomination by their respective CCEs, COCs / CCs on disease groups or Chief Pharmacist as appropriate.